Clinical trial
Late Phase II Study of TS-142 in Patients with Insomnia
NCT04469023 is registered in ClinicalTrials.gov with Taisho Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Late Phase II Study of TS-142 in Patients with Insomnia
- Lead sponsor
- Taisho Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 9, 2020
- Completion date
- November 16, 2021
- Enrollment
- 179 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patients with insomnia